Microsatellite instability (MSI) is an important marker for screening for hereditary nonpolyposis colorectal cancer (Lynch syndrome) as well as a prognostic and predictive marker for sporadic colorectal cancer (CRC). The mononucleotide microsatellite marker panel is a well-established and superior alternative to the traditional Bethesda MSI analysis panel, and does not require testing for corresponding normal DNA. The most common MSI detection techniques-fluorescent capillary electrophoresis and denaturing HPLC (DHPLC)-both have advantages and drawbacks. A new high-resolution melting (HRM) analysis method enables rapid identification of heteroduplexes in amplicons by their lower thermal stability, a technique that overcomes the main shortcomings of capillary electrophoresis and DHPLC.
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Microsatellite instability (MSI) 3 is a form of genomic instability that occurs because of failure of the mismatch repair (MMR) system to correct either insertion or deletion of repeating units during DNA replication. MSI is a well-established marker for screening for hereditary nonpolyposis colorectal cancer (HNPCC) (Lynch syndrome) (1 ) as well as a prognostic marker (2, 3 ) that occurs in approximately 15%-20% of patients with sporadic colorectal cancer (CRC) and approximately 90% of patients with Lynch syndrome (4 ) .
Traditionally, a diagnosis of MSI in CRC is based on the PCR-based panel of 5 microsatellite markers (2 mono-and 3 dinucleotide repeats) proposed by the National Cancer Institute Research Workshop in Bethesda, Maryland (5 ) . This method has substantial limitations, however, because of the inclusion of less sensitive and less specific dinucleotide markers (6, 7 ) . The current standard approach of MSI analysis is relatively time-consuming, laborious, and expensive, because allelic profiles between tumor and matching germlineand normal-tissue DNA must be compared (6, 8 ) . Recently the exclusive use of traditional (BAT25 and BAT26) and/or novel (CAT25, SEC63, NR-21, NR-22, NR-24, and NR-27) monomorphic mononucleotide repeat markers in various combinations has been successfully applied by some groups (6, 8 -13 ) . These markers have proven to be superior to the National Cancer Institute panel for the detection of tumors with an altered MMR system and do not require the analysis of corresponding normal DNA (9, 14, 15 ) . The use of mononucleotide repeats such as BAT25 [an intronic T25 sequence in the v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT) gene 4 ] and BAT26 [an intronic A26 sequence in the mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) (MSH2) gene] has proven to be very useful for the identification of the MSI-positive [MSI(ϩ)] group of tumors (16 ) .
Current MSI testing techniques involve fluorescent PCR-based assays followed by capillary electrophoresis (CE) of resulting fragments or DNA sequence analysis by denaturing HPLC (DHPLC). DHPLC is based on hetero-or homo-duplex formation and melting-temperature-dependent migration of reannealed amplicons through a solid-phase column. DHPLC has advantages over the CE-based methods because it is free of the stutter peaks inherent to CE, thus conferring better interpretation (17, 18 ) .
One major drawback of DHPLC is that because of multiple amplicon melting temperatures the column temperature must be optimized for each target to achieve the optimal degree of denaturation (19 ) . Serial open-tube post-PCR sample-loading elution steps are relatively toxic and labor intensive, and the resulting increase in complexity decreases throughput.
A new closed-tube post-PCR method of highresolution melting (HRM) analysis (20 ) with fully saturating double-stranded DNA dyes is a potentially useful technique for sequence variation assessment. Simplicity, low cost, ease of use, and high sensitivity and specificity are the most prominent features that make HRM analysis an attractive new maintenancefree tool for genotyping and application in diagnostic laboratories (21 ) .
Intrinsically, HRM is based on the analysis of melting properties (transition profile from double-to single-stranded phase in particular) of formed heteroduplexed amplicons, and is similar to other heteroduplex detection-based techniques such as DHPLC. The melting profile of the amplicons depends on their guanine-cytosine content, length, sequence, and heterozygosity. Changes in the nucleotide sequence will give rise to the formation of the heteroduplexes that change the shape of the melting curve compared with the wild-type melting profile (20, (22) (23) (24) . These observations led us to hypothesize that the HRM technique could be used to reveal heteroduplexes formed in MSI(ϩ) tumors due to change in the length (from insertions or deletions) of microsatellites and that with this method the formation and analysis of stutter peaks could be avoided.
Here we describe a novel approach for MSI detection by using HRM analysis of 2 mononucleotide repeats in formalin-fixed paraffin-embedded (FFPE) samples from colorectal tumors. We evaluated HRM analysis for 2 MSI markers (BAT25 and BAT26) and compared 2 HRM-enabled instruments, the LightCycler 480 (LC480) (Roche Diagnostics) and the LightScanner (LS) (Idaho Technology). We also determined the analytical sensitivity and specificity of the HRM assay on a total number of 130 amplicons from 65 CRC samples [11 MSI(ϩ) and 54 microsatellite stable (MSS)] on both instruments.
Materials and Methods

SAMPLES AND DNA PREPARATION
Archival FFPE samples from 70 white individuals with histologically confirmed CRC were obtained from the National Pathology Centre (Vilnius, Lithuania). Molecular analysis was performed in the Laboratory of Molecular Medicine of the Vilnius University Hospital Santariskiu Clinics. Areas enriched in cancer cells (Ͼ75% of all cells) were marked by a pathologist and used for tumor DNA preparation. After manual microdissection, tumor DNA was isolated by using the QIAamp DNA Mini Kit (Qiagen) according to the protocol for fixed tissues. The quantity and quality of isolated DNA samples were assessed with a NanoDrop 2000 (Thermo Scientific) spectrophotometer. Some CRC samples were subjected to KRAS/BRAF testing and have been described previously (25 ) . The study was approved by an institutional ethics committee.
MSI TYPING BY MULTIPLEX FLUORESCENT-PCR-BASED CE
For the amplification of the mononucleotide marker panel, we used HPLC-purified Cy5 (for BAT26) and IRD700 (for BAT25) labeled forward and unlabeled reverse primers obtained from Metabion. The sequence of primers has been published elsewhere (17 ) and was as follows for BAT26 (forward 5Ј-TGACTACTTTTGACTTCAGCC-3Ј, reverse 5Ј-AA-CCATTCAACATTTTTAACCC-3Ј) and BAT25 (forward 5Ј-TCGCCTCCAAGAATGTAAGT-3Ј, reverse 5Ј-TCTGCATTTTAACTATGGCTC-3Ј).
Multiplex PCR was carried out in Maxima Using the mononucleotide marker panel, we defined a tumor as MSI(ϩ) when it showed instability with at least 1 mononucleotide BAT26 marker or with 2 mononucleotide markers (BAT25 and BAT26), and MSS when it showed no instability for 2 markers. Eleven samples were typed as MSI(ϩ) and confirmed twice by new PCR and subsequent fragment analysis. One sample was unstable for the BAT26 marker only.
PCR-HRM ASSAY AND ANALYSIS
The sequences of primers were the same as those used in the fluorescence-based MSI typing, excluding fluorophore labeling. The DYNAMelt Web Server (26 ) was used for the determination of the folding characteristics and melting domains of the amplicons.
The PCR amplification mixture included 0.2 mol/L of deoxynucleoside 5Ј-triphosphate/deoxyuridine 5Ј-triphosphate (dNTP/dUTP) mix (Fermentas), 3 mmol/L MgCl 2 (Fermentas), 10X Hot Start PCR buffer (diluted to 1ϫ; Fermentas), 4 pmol of each primer, 0.5 U of Maxima Hot Start Taq DNA polymerase (Fermentas), and 5 mol/L of SYTO9 dye (Invitrogen) plus approximately 10 ng DNA with PCR-high-grade DEPCtreated water (Fermentas) adjusted to a final volume of 10 L. To prevent carryover contamination, 0.25 U of uracil-DNA glycosylase (Fermentas) was added in the PCR. PCR mixes were dispensed manually into HRM-compatible 96-well (LC480, Roche Diagnostics) and 384-well plates (LS, 4Titude). The plates were sealed with HRM-compatible sealing foil (Roche Diagnostics). To prevent evaporation during HRM heating on the LS, PCR products on 384-well plates were covered with a mineral oil overlay. A 10-min centrifugation step (1000g) was used to eliminate the air bubbles. All reactions were performed in duplicates in 3 runs on 96-well plates in an LC480, and in a single run on TProfessional Standard 384 thermocycler (Biometra).
The amplification conditions included a uracil-DNA glycosylase-treatment step at 50°C for 2 min and an initial denaturation and polymerase activation step at 95°C for 10 min, followed by 5 cycles of denaturation at 95°C for 15 s, touchdown annealing starting at 60°C for 30 s (decreasing 1°C per cycle), extension at 72°C for 30 s, and an additional 33 cycles of denaturation at 95°C for 15 s, annealing at 53°C for 30 s, and extension at 72°C for 30 s. Before the HRM step, the products were heated to 95°C for 1 min and cooled to either 40°C (on the LC480) or 25°C (on the LS) for 1 min, allowing heteroduplex formation.
On the LC480 instrument HRM was carried out and the data collected over the range from 55 to 95°C, rising at 0.1°C/s with 25 acquisitions/s. The plates on the LS were heated from 60 to 95°C at 0.1°C/s.
Gene Scanning Software (version 1.5; Roche) and LightScanner software (version 2.0; Idaho Technology) were used for analysis of melting curves obtained on the LC480 and LS, respectively. Briefly, the raw melting-curve data were normalized by manual adjustment of linear regions before (pre-or 100% fluorescence) and after (post-or 0% fluorescence) the melting transition according to the instrument manuals on both software versions. Normalized and temperatureshifted curves were further automatically subtracted from assigned reference curves to generate difference plots (curves) that were automatically clustered into separate groups (Autogroup function). Internal instrument-sensitivity settings of 0.3 and 0.5 were used on the LC480, whereas "normal" and "high" sensitivity settings were applied on the LS. Samples with both duplicates assigned for variant groups were scored as MSI(ϩ) and samples with at least 1 curve assigned as a reference were scored as normal (MSS).
CALCULATION OF ANALYTICAL SENSITIVITY AND SPECIFICITY
Analytical sensitivity [a proportion (%) of positive tests if the MSI was present] was calculated as the number of true-positive samples divided by a sum of true-positive and false-negative (FN) samples, multiplied by 100. Analytical specificity [a proportion (%) of negative tests if the MSI was not present] was defined as the number of true-negative samples divided by the sum of true-negative and false-positive (FP) samples, multiplied by 100.
Results
To evaluate the analytical sensitivity and specificity of the HRM approach, we used this method to test 2 mononucleotide BAT25 and BAT26 markers in a total of 70 CRC samples. Amplification and HRM analysis for BAT25 and BAT26 markers was possible in 93% (65 of 70) of tested tumor samples, generating a total of 130 amplicons. We characterized the MSI status for all CRC samples by fluorescence-labeled mononucleotide microsatellite repeat markers (BAT25 and BAT26) by CE (Fig. 1, A and B) .
ANALYTICAL SENSITIVITY
To determine the analytical sensitivity of the MSI-HRM method, we used 11 known unstable tumor samples: 10 unstable for both BAT25 and BAT26 markers and 1 unstable for the BAT26 marker. Among 11 MSI(ϩ) samples there were 6 tumor samples from previously genetically confirmed Lynch syndrome patients [1 with a mutated mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) (MLH1) gene and 5 with a mutated MSH2 gene]. MSI(ϩ) samples were caused by deletion mutations in mononucleotide markers, ranging from Ϫ2 to Ϫ11 length shift (number of deleted nucleotides) for the BAT25 marker and from Ϫ5 to Ϫ11 for the BAT26 marker (Table 1) . MSI analysis of a total of 70 samples [11 MSI(ϩ) and 59 MSS] was performed on 2 different HRM-enabled platformsthe 384-well plate LS (Idaho Technology) and the realtime 96-well plate LC480 (Roche) instruments. To determine the analytical sensitivity for the BAT25 marker, only 10 samples unstable for BAT25 marker were included in the calculations [MSI BAT25 (ϩ)]. With the LS platform, sequence variations representing aberrant heteroduplex melting curves were detected in 10 of 10 MSI BAT25 (ϩ) cases (analytical sensitivity 100%) for the BAT25 marker (using the "high" instrument-sensitivity setting) and in 11 of 11 MSI(ϩ) cases (analytical sensitivity 100%) for the BAT26 marker (Fig. 1, C and D) . However, at the default "normal" instrument sensitivity setting, the analytical sensitivity dropped to 71.4% (4 FN samples) and 78.6% (3 FN samples) for BAT25 and BAT26 markers, respectively (Table 2) .
On the LC480 instrument, 1 sample of 10 MSI BAT25 (ϩ) and 1 of 11 MSI(ϩ) were not detected with the default instrument 0.3 sensitivity setting for the unstable BAT25 and BAT26 markers, respectively (analytical sensitivities of 90.9% and 91.7%, respectively). Increasing the instrument sensitivity setting to 0.5 led to 100% detection sensitivity for the BAT25 and BAT26 markers (10 of 10 and 11 of 11, respectively) ( Tables 1 and 2 ; Fig. 1, E and F) . 
ANALYTICAL SPECIFICITY
To evaluate the specificity of the HRM analysis method, 2 operators performed an independent HRM analysis for BAT25 and BAT26 markers on previously confirmed 54 MSS samples on each of the HRM platforms. Operators who were blinded to other results analyzed data from each other's runs; generated reports were then compared. The analysis was performed on "normal" and "high" instrument-sensitivity settings on the LS and 0.3 and 0.5 sensitivity settings on the LC480. At the default sensitivity settings on the LC480 and LS (0.3 and "normal," respectively) we observed no FP samples for the BAT25 marker, i.e., an analytical specificity of 100% compromised by analytical sensitivity of 90.9% and 71.4%, respectively, on 2 platforms (Table  2 ). One FP sample was observed on the LC480 (but none on the LS) for the BAT26 marker (analytical specificity 98.4% on LC480 vs 100% on LS). When instrument sensitivity settings were increased (0.5 on LC480 and "high" on LS), the analytical specificity dropped to 93.1% on LC480 (4 FP samples) and to 98.2% on LS (1 FP sample) for the BAT25 marker and was 91.5% (5 FP samples) and 100% (0 FP samples) for the BAT26 marker, respectively, on 2 instruments (Table 2) .
Discussion
Currently, the most widely used techniques for MSI analysis are based on fluorescence-related PCR assays followed by CE or DHPLC (27 ) . To overcome the drawbacks of these methods (stutter peaks observed in CE and the complexity of DHPLC), we developed a novel and simple approach for MSI detection by an HRM analysis method using the set of 2 most commonly used mononucleotide markers (BAT25 and BAT26). The analysis of tumor DNA without the corresponding normal tissue/DNA is already a wellestablished approach for MSI detection (6, 8 -12, 14 ) and mononucleotide markers are being suggested to replace dinucleotide markers (7, 13 ) . BAT26 has some advantages over other markers in MSI analysis because it has better analytical sensitivity than other markers and shows negligible allele size variation. Furthermore, results of several studies support the use of BAT26 alone on tumor DNA (28 ) . Of the 11 MSI(ϩ) tumor samples, 1 sample showed instability with the BAT26 marker only, which is in agreement with the higher analytical sensitivity of this marker. BAT25 and BAT26 markers are known to be quasimonomorphic, with very rare germline polymorphisms in the white population (0.08%) (29 ) .
The analytical sensitivity and specificity of HRM depends on the dye, instrument, and software used (30 ) . In this study we evaluated and validated HRM analysis for MSI detection on 2 distinct instruments. We evaluated the HRM method for 2 MSI markers (BAT25 and BAT26) on the 96-well plate LC480 and the 384-well plate LS instruments, and implemented HRM analysis software modules. Sixty-five archival FFPE colorectal tumor samples (in total 130 amplicons) were amplified by use of double-stranded DNA saturating dye SYTO9.
To retain appropriate analytical sensitivity, amplicons used for HRM analysis should be no longer than 300 bp and contain no more than 2 melting domains. Previously reported sets of primers for BAT25 and BAT26 allowed us to obtain 2 fragments (124 and 122 bp, respectively) suitable for the HRM analysis. Each of the generated BAT25 and BAT26 marker amplicons had only 1 melting domain, which was predicted by DYNAMelt software and was visible in the melting profile of the curves.
We detected all known MSI(ϩ) samples on both the LC480 (sensitivity setting 0.5) and the LS (sensitivity setting "high") both for BAT25 and BAT26 markers, thus confirming 100% analytical sensitivity of the 2 platforms. These results are in agreement with those of previous studies that compared the results for both instruments of HRM assays on genomic DNA, although those studies used older software modules (31, 32 ) . Good DNA quality is essential for HRM analysis; therefore, high-yield genomic DNA from peripheral blood leukocytes or saliva is the preferred material for analysis. However, the technique has already been successfully employed to scan for somatic mutations in various genes in archival FFPE tissues prone to DNA fragmentation (33 ) , which is particularly appealing for retrospective studies and is within the framework of specimen processing in clinical pathology (34 ) . To the best of our knowledge, our study is the first evaluation of 2 different instruments and implemented software modules for HRM assay on tumor DNA extracted from archival tumor material and of MSI detection by HRM.
With instrument sensitivity on default settings, LC480 (sensitivity setting 0.3) performed better for BAT25 and BAT26 markers than LS (sensitivity setting "normal"), giving fewer FN results (Tables 1 and 2) . However, to reach 100% analytical sensitivity on both platforms and overcome FN results, we recommend analysis of samples on sensitivity setting 0.5 for LC480 and "high" for LS.
For analytical specificity, LS scored slightly better than LC480 on 0.3 and 0.5 sensitivity settings. Using the "high" instrument sensitivity setting, we obtained 100% analytical sensitivity and specificity on LS for the BAT26 marker, and on the "normal" setting we retained 100% analytical specificity. On the LC480, when the instrument sensitivity was increased from the default setting of 0.3-0.5, 4 additional samples were assigned as FP, which reduced the analytical specificity from 98.4% to 91.5%. For the BAT25 marker the analytical specificity was better on the LS (98.2%, 1 FP sample) than on the LC480, on which it was reduced from 100% to 93.1% owing to 4 FP samples identified when the sensitivity setting was increased from 0.3-0.5.
Combining the results obtained for the 2 MSI markers on the 2 different instruments, we found analytical specificities of 92.3% and 99.1% on LC480 and LS platforms, respectively (at 0.5 and "high" sensitivity settings), which fall within the reported range of 90%-100% for HRM (35 ) . The analytical specificity may be higher with shorter amplicons and usually is adversely affected by sample quality (35 ) .
In some duplicates with 1 curve assigned for reference (MSS), we observed a slight deviation of the second curve, but this declination was always observed in the opposite direction from MSI(ϩ) and could not be misinterpreted and thus affect analytical sensitivity or specificity. This deviation might have been attributable to pipetting errors, which can be minimized by use of robotic equipment. In general, our observations are in agreement with the standard HRM interpretation rule, proposed by von der Stoep et al., that once a sample is tested as a wild-type curve, the sample will not contain a variant even if it shows some deviation in the other melting step (24 ) .
On the LC480, for MSI(ϩ) samples some differently colored groups emerged when the sensitivity settings were increased, a result that presumably reflected different deleted nucleotide numbers. Generally, we found the LS software visualization to be more consistent and easier to interpret.
We did not observe a trend that samples with fewer deleted nucleotides were more likely to be missed by HRM. Indeed, HRM efficiently detects even single base-pair heterozygous changes (33 ) .
In our MSI study, we failed to amplify 5 samples. Successful amplification of MSI markers depends on the quality of isolated DNA and might be improved by using methanol-fixed tissues, in which DNA is better preserved than in formalin-fixed tissues (36 ) and also give fewer FN/FP results (33 ) . In addition, for good HRM analysis amplification curves should produce a crossing point (quantification cycle) Ͻ30.
The HRM technique avoids the need for timeconsuming DNA fragment analysis by CE and is a useful technique for high-throughput MSI screening analyses. The performance of PCR in replicates is essential because it reduces the influence of subtle variation observed between the samples. HRM analysis is similar to DHPLC in that both methods identify heteroduplexes by their lower thermal stability, and HRM has been shown to be comparable to DHPLC in terms of its analytical sensitivity and specificity (19 ) . Major drawbacks of the DHPLC method are chemical waste, high maintenance cost, the need for post-PCR manipulations, and low throughput (37 ) . Unlike DHPLC, HRM analysis scans through a range of temperatures rather than depending on a specific temperature that requires intensive optimization for each run.
The detection of MSI by RT-PCR and hybridizationprobe melting-point analysis has been described (38 ) , although it has not found substantial applicability. HRM analysis with saturating DNA dyes as a scanning tool for heteroduplex identification has apparent advantages, including assay design simplicity, no post-PCR manipulation, accuracy, versatility, speed of analysis, and cost efficiency (19, 37 ) . If necessary, more mononucleotide MSI markers can be easily incorporated into HRM analysis.
One potential drawback of HRM is limited ability to multiplex, although multiplex HRM analysis of up to 4 small amplicons has been achieved (33 ) . This disadvantage and the need for replicates could affect the claimed cost-effectiveness of this method, but only marginally.
In conclusion, our HRM analysis results suggest that this method has a high sensitivity for discrimination of MSI(ϩ) samples from MSS samples. BAT25 and BAT26 are analytically sensitive and specific markers for the detection of the MSI(ϩ) phenotype in cancer. We have successfully implemented HRM assays for MSI typing, which can be especially suitable in routine workflow for Lynch syndrome screening (39 ) and prognostic or predictive status assessment for sporadic stage II colorectal tumors (40 ) .
